FDA Snubs Allergan, GNMX Gets Attention, Another Month, Another Suitor For CBPO

Today's Daily Dose brings you news about the upcoming clinical trial catalyst of Aevi Genomic; the Complete Response Letter issued for Allergan's Ulipristal acetate; China Biologic's new suitor, and Rexahn Pharma's deal with Merck.

from RTT - Biotech https://ift.tt/2BzaBhh
via IFTTT